JIN MEDICAL INTERNATIONAL LT (ZJYL)
KYG5140V1124 - Common Stock
Overall ZJYL gets a fundamental rating of 4 out of 10. We evaluated ZJYL against 192 industry peers in the Health Care Equipment & Supplies industry. ZJYL has an excellent financial health rating, but there are some minor concerns on its profitability. ZJYL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ZJYL was profitable.
In the past year ZJYL had a positive cash flow from operations.
Each year in the past 5 years ZJYL has been profitable.
In multiple years ZJYL reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 14.42%, ZJYL belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
ZJYL has a better Return On Equity (18.99%) than 92.71% of its industry peers.
With an excellent Return On Invested Capital value of 12.33%, ZJYL belongs to the best of the industry, outperforming 94.79% of the companies in the same industry.
ZJYL had an Average Return On Invested Capital over the past 3 years of 13.21%. This is above the industry average of 8.42%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 18.99% | ||
| ROIC | 12.33% |
ROA(3y)11.86%
ROA(5y)14.64%
ROE(3y)19%
ROE(5y)26.39%
ROIC(3y)13.21%
ROIC(5y)19.93%
1.3 Margins
Looking at the Profit Margin, with a value of 15.19%, ZJYL belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
ZJYL's Profit Margin has declined in the last couple of years.
ZJYL has a better Operating Margin (13.25%) than 83.85% of its industry peers.
ZJYL's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 33.04%, ZJYL is doing worse than 71.35% of the companies in the same industry.
ZJYL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.25% | ||
| PM (TTM) | 15.19% | ||
| GM | 33.04% |
OM growth 3Y-19.9%
OM growth 5YN/A
PM growth 3Y-7.63%
PM growth 5YN/A
GM growth 3Y-4.3%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZJYL is still creating some value.
The number of shares outstanding for ZJYL remains at a similar level compared to 1 year ago.
ZJYL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ZJYL has an Altman-Z score of 40.68. This indicates that ZJYL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 40.68, ZJYL belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
ZJYL has a debt to FCF ratio of 0.34. This is a very positive value and a sign of high solvency as it would only need 0.34 years to pay back of all of its debts.
ZJYL has a Debt to FCF ratio of 0.34. This is amongst the best in the industry. ZJYL outperforms 92.19% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that ZJYL is not too dependend on debt financing.
ZJYL has a Debt to Equity ratio of 0.06. This is comparable to the rest of the industry: ZJYL outperforms 58.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.34 | ||
| Altman-Z | 40.68 |
ROIC/WACC1.52
WACC8.13%
2.3 Liquidity
A Current Ratio of 3.89 indicates that ZJYL has no problem at all paying its short term obligations.
The Current ratio of ZJYL (3.89) is comparable to the rest of the industry.
A Quick Ratio of 3.02 indicates that ZJYL has no problem at all paying its short term obligations.
With a Quick ratio value of 3.02, ZJYL perfoms like the industry average, outperforming 58.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.89 | ||
| Quick Ratio | 3.02 |
3. Growth
3.1 Past
ZJYL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.09%.
The Earnings Per Share has been decreasing by -9.59% on average over the past years.
Looking at the last year, ZJYL shows a decrease in Revenue. The Revenue has decreased by -2.61% in the last year.
The Revenue has been decreasing by -1.97% on average over the past years.
EPS 1Y (TTM)-91.09%
EPS 3Y-9.59%
EPS 5YN/A
EPS growth Q2Q70.5%
Revenue 1Y (TTM)-2.61%
Revenue growth 3Y-1.97%
Revenue growth 5YN/A
Revenue growth Q2Q8.3%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ZJYL is valuated quite expensively with a Price/Earnings ratio of 97.33.
66.15% of the companies in the same industry are more expensive than ZJYL, based on the Price/Earnings ratio.
ZJYL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.60.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 97.33 | ||
| Fwd PE | N/A |
4.2 Price Multiples
67.19% of the companies in the same industry are more expensive than ZJYL, based on the Enterprise Value to EBITDA ratio.
71.35% of the companies in the same industry are more expensive than ZJYL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 105.57 | ||
| EV/EBITDA | 106.96 |
4.3 Compensation for Growth
The decent profitability rating of ZJYL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ZJYL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
JIN MEDICAL INTERNATIONAL LT
NASDAQ:ZJYL (5/20/2024, 1:31:56 PM)
2.92
-0.08 (-2.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap457.13M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 97.33 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 18.99% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.25% | ||
| PM (TTM) | 15.19% | ||
| GM | 33.04% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.89 | ||
| Quick Ratio | 3.02 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-91.09%
EPS 3Y-9.59%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.61%
Revenue growth 3Y-1.97%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y